RxDoctor Payments DataLook up a doctor →

Angela Moore, MD

Dermatopathology · Arlington, TXNPI 1235142266

Payments from drug & device makers

$9,472,490in general payments, 2019–2025

Across 2,657 payments — averaging $3565.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2M
  • Janssen Research & Development, LLC$1.8M
  • Eli Lilly$1.3M
  • Incyte Corporation$707K
  • Sanofi US Services Inc.$641K
  • UCB SA$529K
  • plus $2.5M from 49 others
$38,787in research payments, 2019–2025

Across 3 payments — averaging $12,929 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Almirall LLC$28K
  • Biofrontera Inc.$11K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)493$2,029,482
Janssen Research & Development, LLC273$1,835,452
Eli Lilly30$1,263,090
Incyte Corporation420$707,344
Sanofi US Services Inc.22$641,088
UCB SA30$528,594
Takeda Pharmaceuticals U.S.A., Inc.46$485,786
Pfizer161$430,769
Almirall LLC134$313,021
Acrotech Biopharma Inc.16$207,848
E.r. Squibb & Sons, L.L.C.39$158,004
VYNE Pharmaceuticals Inc.73$143,354
Galderma Research & Development, LLC111$138,419
Novartis79$130,663
Arcutis Biotherapeutics, Inc.104$109,365
Aclaris Therapeutics, Inc.23$69,619
Verrica Pharmaceuticals Inc.39$46,062
Biofrontera Inc.30$45,290
Dermira, Inc.13$37,012
Galderma Laboratories, L.p.20$35,014
Sun Pharmaceutical Industries Inc.20$29,739
Boehringer Ingelheim International GmbH12$18,854
Hoffmann-la Roche Limited7$14,471
Genentech, Inc.8$13,292
UCB, Inc.34$10,284
Janssen Global Services, LLC7$6,140
LEO Pharma AS9$4,499
Johnson & Johnson35$3,288
Fresenius Kabi USA, LLC3$3,079
EPI Health, LLC3$2,663
LEO Pharma Inc.27$2,508
Mayne Pharma Commercial LLC220$2,151
Janssen Scientific Affairs, LLC15$1,667
Lilly USA, LLC15$848
Amgen8$632
Sanofi6$559
Paratek Pharmaceuticals, Inc.20$502
GSK4$358
Sandoz10$304
Bristol Myers Squibb2$230
Ortho Dermatologics, A Division Of Bausch Health US, LLC6$207
Actelion Pharmaceuticals US, Inc.1$125
Organon1$106
Sebela Pharmaceuticals Inc.7$101
Springworks Therapeutics, Inc.2$100
Regeneron Healthcare Solutions, Inc.4$100
Journey Medical Corporation3$90
Dermavant Sciences, Inc.3$86
Tempus AI, Inc1$73
Encore Dermatology Inc.3$47
Elekta, Inc.1$33
Promius Pharma LLC1$23
DUSA Pharmaceuticals, Inc.1$21
Nabriva Therapeutics, PLC1$19
Botanix SB Inc1$15

How this compares

$9,472,490 in reported general payments places this provider in the 95th percentile of 54 dermatopathology providers in Texas.

See all dermatopathology providers in Texas

Medicare billing

Part B allowed, 2024
$988,756
Medicare patients
717
Services billed
66,257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatopathology in Arlington

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →